By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.
Tim FerrissPsychedelics — Microdosing, Mind Enhancing Methods, and More | The Tim Ferriss Show (Podcast)
Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.
Episode Details
EPISODE INFO
- Released
- August 7, 2019
- Duration
- 1h 3m
- Channel
- Tim Ferriss
- Watch on YouTube
- ▶ Open ↗
EPISODE DESCRIPTION
This episode features a panel that I moderated in front of a standing-room-only crowd at the Milken Institute’s Global Conference 2019. It includes a great overview of psychedelic science, investing opportunities, anecdotal personal benefits, legal challenges, and much more. I think it’s one of the more comprehensive panels ever done on the subject. Here are the participants: Matthew Johnson — Principal Investigator, Johns Hopkins Psychedelic Research Unit Ayelet Waldman — Author, A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My Life Robin Carhart-Harris — Head of Psychedelic Research, Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London Christian Angermayer — Founder, Apeiron Investment Group and ATAI Life Sciences Please enjoy! 00:00 Start 03:25 An encouraging psychedelics story 06:02 The key to responsible research (Link to download Matthew's slides can be found in the Show Notes section at https://tim.blog/2019/07/15/psychedelics-microdosing-mind-enhancing-methods/) 07:21 Effect on mental health and addiction 12:17 Effects of microdosing 16:48 How psychedelics work 21:37 Bringing psychedelics back into the legal realm 28:16 Treating PTSD with MDMA 31:41 Potential toxicity 37:33 Effect on opioid addiction 40:45 On diagnostic categories 45:48 Prescription vs. over-the-counter 47:04 Decriminalization and the psychedelic spa 47:59 The Netherlands problem 48:39 A sustainable business model 52:54 How to reclassify psychedelic drugs 59:16 Hopes for the future SUBSCRIBE: http://bit.ly/1dSzTkW About Tim Ferriss: Tim Ferriss is one of Fast Company’s “Most Innovative Business People” and an early-stage tech investor/advisor in Uber, Facebook, Twitter, Shopify, Duolingo, Alibaba, and 50+ other companies. He is also the author of five #1 New York Times and Wall Street Journal bestsellers: The 4-Hour Workweek, The 4-Hour Body, The 4-Hour Chef, Tools of Titans and Tribe of Mentors. The Observer and other media have named him “the Oprah of audio” due to the influence of his podcast, The Tim Ferriss Show, which has exceeded 400 million downloads and been selected for “Best of iTunes” three years running. Connect with Tim Ferriss: Sign up for "5-Bullet Friday" (Tim's email newsletter): https://go.tim.blog/5-bullet-friday-1/ Visit the Tim Ferriss PODCAST: https://tim.blog/podcast/ Visit the Tim Ferriss BLOG: https://tim.blog/ Follow Tim Ferriss on TWITTER: https://twitter.com/tferriss/ Follow Tim Ferriss on INSTAGRAM: https://www.instagram.com/timferriss/ Like Tim Ferriss on FACEBOOK: https://www.facebook.com/TimFerriss/
SPEAKERS
Tim Ferriss
hostPodcaster and author, host of The Tim Ferriss Show.
Ayelet Waldman
guestAuthor and former lawyer/criminal law professor known for writing about microdosing in A Really Good Day.
Matthew Johnson
guestProfessor of Psychiatry and Behavioral Sciences at Johns Hopkins University researching psychedelics and addiction.
Robin Carhart-Harris
guestNeuroscientist researching psychedelic mechanisms such as the default mode network and therapeutic change.
Christian Angermayer
guestGerman entrepreneur and biotech investor associated with bringing psychedelics to regulated medical markets (e.g., ATAI Life Sciences).
EPISODE SUMMARY
In this episode of Tim Ferriss, featuring Tim Ferriss and Ayelet Waldman, Psychedelics — Microdosing, Mind Enhancing Methods, and More | The Tim Ferriss Show (Podcast) explores A panel on psychedelic therapy: risks, mechanisms, trials, and legalization The episode is a panel discussion on psychedelic science and policy recorded at the 2019 Milken Institute Global Conference, featuring researchers, an investor, and an author discussing both data and lived experience.
RELATED EPISODES